Study of APD421 as PONV Treatment (Prior Prophylaxis)

Summary

Double-blind, randomised, parallel-group, placebo-controlled, adaptive, seamless, dose-selecting study to compare the efficacy of APD421 to placebo as treatment of established PONV, in patients who have had prior PONV prophylaxis.

Timeline

Start

2016-03

Primary completion

2017-01

Completion

2017-01

Drugs

Indications

No indication recorded.